2021
DOI: 10.1016/j.jddst.2021.102342
|View full text |Cite
|
Sign up to set email alerts
|

Doxorubicin delivery to breast cancer cells with transferrin-targeted carbon quantum dots: An in vitro and in silico study

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
17
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
8
1

Relationship

2
7

Authors

Journals

citations
Cited by 32 publications
(17 citation statements)
references
References 37 publications
0
17
0
Order By: Relevance
“…This technique is a potential strategy for designing and fabricating novel electrocatalysts with customizable doping composition and electronic architectures because of its simple synthetic procedure and variable hetero-atom doping. (Mahani et al, 2021). Similarly, Sahoo et al reported hydrothermal fabrication of NiS-CQDs from lime juice for supercapacitor applications with a specific capacity of 880 Fg −1 at a current density of 2 Ag −1 .…”
Section: Hydrothermal/solvothermal Methodsmentioning
confidence: 96%
“…This technique is a potential strategy for designing and fabricating novel electrocatalysts with customizable doping composition and electronic architectures because of its simple synthetic procedure and variable hetero-atom doping. (Mahani et al, 2021). Similarly, Sahoo et al reported hydrothermal fabrication of NiS-CQDs from lime juice for supercapacitor applications with a specific capacity of 880 Fg −1 at a current density of 2 Ag −1 .…”
Section: Hydrothermal/solvothermal Methodsmentioning
confidence: 96%
“…In the FRET process, NCDs transferred their energy to the quencher AuNPs, and thus, their fluorescence was quenched. It is essential for the FRET process that the donor emission spectrum overlaps the absorption spectrum of the acceptor which expresses a large influence on measured transfer efficiency [ 33 ]. In Figure S2A , the absorption spectrum of the AuNPs overlaps with the emission spectrum of NCDs.…”
Section: Resultsmentioning
confidence: 99%
“…The nanocarrier at pH = 7.4 showed good stability, and only 18% of the DOX was released within 10 h; however, at pH = 5.2, ca. 50% of the drug was released within 24 h. The DOX-loaded TF-CDs conjugate was also used for cell tracking in MCF-7 cells …”
Section: Cds As a Targeted Nanocarrier For Cancer Treatmentmentioning
confidence: 99%
“…Chemotherapeutics are attached with CDs via covalent or noncovalent bonds; both techniques are significant for drug attachment with CDs due to the existence of numerous intrinsic binding sites including amine, carboxyl, and hydroxyl on their surfaces . These functionalities allow the conjugation of chemotherapeutics on their surface and are able to release the payloads after coming in contact with some definite environment like acidic pH, reactive oxygen species (ROS), reactive sulfur species (RSS), reactive nitrogen species (RNS), and other abundant small molecules present in cancer cells and to prevent the premature release of chemotherapeutics in normal physiological conditions. Furthermore, it is also possible to simultaneously conjugate drug and targeting ligands on the surface of CDs, which provides receptor targeting capabilities to CDs …”
Section: Cds As a Targeted Nanocarrier For Cancer Treatmentmentioning
confidence: 99%